Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People

PHASE2CompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
HIV Infections
Interventions
DRUG

IL-2

7.5 MIU injected intramuscularly; one arm uses Proleukin together with HAART of choice (protease inhibitor and at least 2 nucleoside/nucleotide reverse transcriptase inhibitors)

Trial Locations (36)

1199

Hosp. Italiano de Buenos Aires, Infectious Diseases Section CRS, Ciudad de Buenos Aires

1221

Hosp. Gen. de Agudos JM Ramos Mejia, Servicio de Inmunocomprometidos CRS, Ciudad de Buenos Aires

2010

St. Vincent's Hospital CRS, Darlinghurst

3053

Carlton Clinic CRS, Carlton

4000

Queensland Health - AIDS Med. Unit CRS, Brisbane

4101

Gladstone Road Medical Ctr. CRS, Highgate Hill

4220

Gold Coast Sexual Health Clinic CRS, Miami

10037

Harlem Hospital Ctr./Columbia University CRS (Gordin CTU), New York

10451

Lincoln Hosp. & Med. Ctr. CRS, The Bronx

20127

Ospedale San Raffaele S.r.l. CRS, Milan

20157

Univ. of Milan, Ospedale Luigi Sacco, Institute of Infectious and Tropical Diseases CRS, Milan

20422

Washington DC VAMC, Washington Regional AIDS Program, Infectious Diseases CRS, Washington D.C.

23298

Virginia Commonwealth Univ. Medical Ctr. CRS, Richmond

48202

Henry Ford Hosp. CRS, Detroit

77030

Michael E. DeBakey VAMC CRS, Houston

Thomas Street Clinic CRS, Houston

78229

South Texas Veterans Health Care System, Immunosuppression Clinic CRS, San Antonio

90073

VA Greater Los Angeles Healthcare System, Infectious Diseases Section CRS, Los Angeles

97213

Providence Portland Med. Ctr., Ambulatory Care and Education Ctr. CRS, Portland

20814-9692

NIH Clinical Ctr., NIAID HIV Clinic CRS, Bethesda

C1425-AWK

Funcei Crs, Ciudad de Buenos Aires

Unknown

Caici Crs, Rosario

Fundacion Arriaran CRS, Santiago

Univ. Hosp. Ctr. of the Med. School of Casablanca, Infectious Diseases Unit CRS, Casablanca

Wojewodzki Szpital Zakazny CRS, Warsaw

Hospital de Cascais, HDDI, Departamento Medicina Interna CRS, Cascais

Hosp. de Egas Moniz, Servicio de Infecciologia e Medicina Tropical CRS, Lisbon

Hosp. de Santa Maria, Servico de Doencas Infecciosas CRS, Lisbon

Hosp. Clinico de Barcelona CRS, Barcelona

Chulalongkorn University Hospital CRS, Bangkok

Chiang Rai Regional Hosp. INSIGHT CRS, Chiangrai

Khon Kaen Univ., Srinagarind Hosp., Div. of Infectious Diseases & Tropical Medicine, Dept. of Medici, Khon Kaen

Brighton & Sussex Univ. Hosp. NHS Trust, HIV Research Office CRS, Elm Grove

Leicester Royal Infirmary, Dept. of Infection & Tropical Medicine CRS, Leicester

EC1A 7BE

St. Bartholomew's Hosp., Infection & Immunity Clinical Group CRS, London

W2 1NY

St. Mary's Hosp. of London, Imperial College School of Medicine CRS, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Chiron Corporation

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH